To assess the clinical relevance harbored by DDX11-AS1 expressions in HCC, the median level of DDX11-AS1 performed the duty of a cutoff point to divide all 374 patients into two groups (high groups: n = 187 and low groups: n = 187). This evidence concerns the gene DDX11 and hepatocellular carcinoma.